HOPE Therapeutics, Inc., a wholly-owned subsidiary of NRx Pharmaceuticals, Inc., announced the signing of a definitive agreement to acquire Dura Medical (Dura). This follows a previously announced non-binding Letter of Intent.
Dura, along with the Neurospa network, is anticipated to provide a comprehensive service offering to patients on Florida's west coast. Dura is a revenue-generating and EBITDA-positive entity, founded in 2018 to offer a precision approach to treating mental health and chronic pain.
Stephen Durand, Dura's founder, will be appointed as Director of Florida Clinic Operations for HOPE. The intended closing of the Dura acquisition is subject to completion of financial audits, regulatory approvals, and the satisfaction of standard closing conditions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.